148 related articles for article (PubMed ID: 22871647)
1. Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives.
Barea C; Pabón A; Galiano S; Pérez-Silanes S; Gonzalez G; Deyssard C; Monge A; Deharo E; Aldana I
Molecules; 2012 Aug; 17(8):9451-61. PubMed ID: 22871647
[TBL] [Abstract][Full Text] [Related]
2. New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities.
Barea C; Pabón A; Pérez-Silanes S; Galiano S; Gonzalez G; Monge A; Deharo E; Aldana I
Molecules; 2013 Apr; 18(4):4718-27. PubMed ID: 23609622
[TBL] [Abstract][Full Text] [Related]
3. New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Quiliano M; Pabón A; Ramirez-Calderon G; Barea C; Deharo E; Galiano S; Aldana I
Bioorg Med Chem Lett; 2017 Apr; 27(8):1820-1825. PubMed ID: 28291694
[TBL] [Abstract][Full Text] [Related]
4. 1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.0(4,9)]tetradecane and derivatives with in vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum.
Howarth J; Wilson D
Bioorg Med Chem Lett; 2003 Jun; 13(12):2013-5. PubMed ID: 12781185
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiplasmodial and antileishmanial activities of herbal medicine Pseudelephantopus spiralis (Less.) Cronquist and isolated hirsutinolide-type sesquiterpenoids.
Girardi C; Fabre N; Paloque L; Ramadani AP; Benoit-Vical F; González-Aspajo G; Haddad M; Rengifo E; Jullian V
J Ethnopharmacol; 2015 Jul; 170():167-74. PubMed ID: 25980423
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives.
Guillon J; Cohen A; Gueddouda NM; Das RN; Moreau S; Ronga L; Savrimoutou S; Basmaciyan L; Monnier A; Monget M; Rubio S; Garnerin T; Azas N; Mergny JL; Mullié C; Sonnet P
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):547-563. PubMed ID: 28114821
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.
Gomes MN; Alcântara LM; Neves BJ; Melo-Filho CC; Freitas-Junior LH; Moraes CB; Ma R; Franzblau SG; Muratov E; Andrade CH
Bioorg Med Chem Lett; 2017 Jun; 27(11):2459-2464. PubMed ID: 28434763
[TBL] [Abstract][Full Text] [Related]
8. A new library of C-16 modified artemisinin analogs and evaluation of their anti-parasitic activities.
Menon RB; Kannoth MM; Tekwani BL; Gut J; Rosenthal PJ; Avery MA
Comb Chem High Throughput Screen; 2006 Dec; 9(10):729-41. PubMed ID: 17168678
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole derivatives endowed with potent antileishmanial activity.
Tonelli M; Gabriele E; Piazza F; Basilico N; Parapini S; Tasso B; Loddo R; Sparatore F; Sparatore A
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):210-226. PubMed ID: 29233048
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions.
Guillon J; Forfar I; Desplat V; Fabre SB; Thiolat D; Massip S; Carrie H; Mossalayi D; Jarry C
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):541-9. PubMed ID: 18035821
[TBL] [Abstract][Full Text] [Related]
17. 4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania.
Manzano JI; Konstantinović J; Scaccabarozzi D; Perea A; Pavić A; Cavicchini L; Basilico N; Gamarro F; Šolaja BA
Eur J Med Chem; 2019 Oct; 180():28-40. PubMed ID: 31299585
[TBL] [Abstract][Full Text] [Related]
18. Antiprotozoal action of synthetic cinnamic acid analogs.
Santos APAD; Fialho SN; Medeiros DSS; Garay AFG; Diaz JAR; Gómez MCV; Teles CBG; Calderon LA
Rev Soc Bras Med Trop; 2018; 51(6):849-853. PubMed ID: 30517542
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new organoselenium compounds as antileishmanial agents.
Al-Tamimi AS; Etxebeste-Mitxeltorena M; Sanmartín C; Jiménez-Ruiz A; Syrjänen L; Parkkila S; Selleri S; Carta F; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():339-345. PubMed ID: 30743174
[TBL] [Abstract][Full Text] [Related]
20. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
